Alabama study aims to boost HIV prevention in At-Risk women
NCT ID NCT05463692
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 37 times
Summary
This study follows 830 cisgender and transgender women in Alabama who are at risk for HIV and sexually transmitted infections (STIs). Researchers want to learn what factors lead to STIs and HIV, and how to improve use of PrEP, a daily pill that prevents HIV. Participants must be HIV-negative, have had a recent STI, and own a smartphone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.